[Federal Register: June 20, 2002 (Volume 67, Number 119)]
[Notices]               
[Page 42059]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20jn02-112]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 8, 2001, Medeva 
Pharmaceuticals CA, Inc., which has changed its name to Celltech 
Manufacturing CA, Inc., 3501 West Garry Avenue, Santa Ana, California 
92704, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
methylphenidate (1724) a basic class of controlled substances listed in 
Schedule II.
    The firm plans to manufacture the listed controlled substance to 
make finished dosage forms for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than August 19, 2002.

    Dated: June 10, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-15570 Filed 6-19-02; 8:45 am]
BILLING CODE 4410-09-M